Xinglin Jiang

Novo Nordisk Foundation

Papers

1

Total Citations

26

H-Index

1

About

Xinglin Jiang is a leading figure in synthetic biology, whose work is revolutionizing the foundational tools of genetic engineering. His primary research focuses on developing affordable, automated, and scalable cloning platforms to overcome critical bottlenecks in the field. Jiang’s most impactful contribution is the "Automating Cloning by Natural Transformation" (2020), a landmark study with 26 citations that has redefined laboratory workflows. By harnessing bacterial natural competence, his team eliminated the need for traditional, equipment-intensive methods like heat shock and electroporation. This innovation dramatically simplifies robotic cloning, making high-throughput genetic assembly more accessible and cost-effective for labs worldwide. Beyond this pivotal paper, Jiang’s work is characterized by a drive to democratize synthetic biology, removing technical and financial barriers that hinder progress. His achievements represent a paradigm shift from complex, manual protocols to streamlined, automated systems, directly enabling faster design-build-test cycles in metabolic engineering and genome editing. For students and researchers, Jiang’s research is a masterclass in elegant problem-solving, showing how a deep understanding of basic biology can unlock powerful, practical solutions for the future of biotechnology.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Automating Cloning by Natural Transformation
26 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Novo Nordisk Foundation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago